SEC Form 4 · accession 0001209191-17-015520
Aravive, Inc. · ARAV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua T Brumm
Officer — COO and CFO
Period of report
Feb 24, 2017
Accepted (ET)
Feb 28, 2017 · 7:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2017 | M | 30,000 | $2.53 | A | 135,779 | D | |
| Common StockF2 | Feb 24, 2017 | S | 18,339 | $20.42 | D | 117,440 | D | |
| Common StockF3 | Feb 24, 2017 | S | 6,008 | $21.46 | D | 111,432 | D | |
| Common StockF4 | Feb 24, 2017 | S | 5,653 | $22.05 | D | 105,779 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $2.53 | Feb 24, 2017 | M | 30,000 | D | — | Dec 4, 2023 | Common Stock | 30,000 | 122,108 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 trading plan.
- F2The shares were sold at prices ranging from $19.90 to $20.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each price.
- F3The shares were sold at prices ranging from $20.90 to $21.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each price.
- F4The shares were sold at prices ranging from $21.90 to $22.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each price.
- F5Twenty-Five percent of the shares subject to the option became exercisable one year from 11/12/2013; the remainder become exercisable in equal monthly installments over the following three years.